Announced Thu, 2 Jul · 13:16 IST
Compliance certificate for share dematerialization, Q1 FY27
Compliance View source PDF
JUBLPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-0.8%1-day move
₹978.00
prior close
₹975.60
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.1-0.2-0.1-0.1-0.8+0.6+0.4-0.6-0.5-0.6-0.5———
Up moveDown movePending
AI summary
Routine SEBI compliance filing. Alankit Assignments, the company's registrar, has confirmed under Regulation 74(5) that physical share certificates received for dematerialization of equity shares during the quarter ended June 30, 2026 were verified, cancelled, and the depository recorded as the registered owner. No material business or financial details disclosed.
Likely market impact
Routine regulatory compliance. No impact on shareholders or stock price.